Form D Explorer
Kayak Therapeutics, Inc. · CIK 2088831

Report a data issueCitable research briefCompare issuerPrivate research collection

Kayak Therapeutics, Inc.

CIK 2088831 · Corporation · Inc. DELAWARE · AUSTIN, Texas · Biotechnology

These Form D notices describe private placements reported to the SEC. Read Form D/A amendments alongside the original disclosures.

Filing history at a glance

The reported offering amount was $25,000,000 in the May 27, 2026 filing and $30,000,000 in the Aug 21, 2026 filing. The two records may concern different offerings. From Sep 29, 2025 to Aug 21, 2026, the explorer stores 2 original notices and 1 amendments.

Filings
3
Original notices
2
Amendments
1
Activity
Sep 29, 2025
through Aug 21, 2026

Figures are issuer-reported and describe stored filings. Data coverage and methodology.

Differences between reported disclosures

Same issuer CIK; offering identity has not been established. Differences are arithmetic comparisons between disclosures, not additional capital raised, new investors or confirmed amendments to the same offering.

Unavailable values are shown as a dash; reported zero remains zero.
FieldMay 27, 2026 · DAug 21, 2026 · D/ALater minus earlier
Reported offering amount$25,000,000$30,000,000$5,000,000
Reported amount sold$11,940,000$24,981,000$13,041,000
Reported investor count5513782
Reported minimum investment$0$0$0

Earlier SEC source: 0002088831-26-000001 · Later SEC source: 0002088831-26-000002

Choose filings to compare · Research this issuer step by step

Latest available filing snapshot: how to read these fields

Form D/A · Aug 21, 2026

Reported offering amount
$30,000,000
Reported exemptions
Rule 506(b)
Reported amount sold
$24,981,000

This is one filing's disclosure, not the issuer's lifetime fundraising or current offering status.

Filings by year

Submission counts, including amendments; not dollars raised or distinct funding rounds.

Form D filings (3)